sabato, 4 dicembre 2021
Medinews
23 Aprile 2019

ASCO and ASH Release Update to Clinical Practice Guidelines for Use of Erythropoiesis-Stimulating Agents

April 17, 2019 – ASCO and the American Society of Hematology (ASH) have released an update to existing guidelines for the use of erythropoiesis-stimulating agents to manage anemia in patients with cancer. The update was simultaneously published in the Journal of Clinical Oncology and Blood Advances. “The current update aims to increase awareness of recent developments regarding the use of erythropoiesis-stimulating agents in patients with cancer. New … (leggi tutto)

TORNA INDIETRO